Parmax Pharma Independent Directors Committee Recommends Open Offer at ₹42.80 Per Share as Fair and Reasonable
The Committee of Independent Directors of Parmax Pharma Limited unanimously recommended the open offer by acquirers Dhiren Chandulal Shah and Sunil Chinubhai Shah, along with ten PACs, as fair and reasonable under SEBI (SAST) Regulations, 2011. The offer seeks to acquire up to 23,46,250 equity shares of face value ₹10.00 each, representing 26.00% of the Expanded Voting Share Capital, at ₹42.80 per share. The IDC noted the offer price is compliant with regulatory benchmarks, while highlighting th